IGFBP3 and hepatocellular carcinoma: WSB2 degrades p53, which leads to decreased IGFBP3 expression and increased AKT Ser 473 phosphorylation, subsequently activating mTOR signaling and contributing to HCC carcinogenesis and metastasis (outlined in Fig. 8).